The measurement of urine protein by the turbidimetric technique using benzethonium chloride produces excellent precision and is easily automated. However, a recent letter by Crofton' casts doubt about the reliability of the method due to positive and negative interferences in the assay compared with a sulphosalicyclic acid (SSA) method.
The positive interferences detected in patients' urine by the benzethonium chloride method were possibly due to non-protein material reacting in the assay. Urine samples with a very high protein concentration can give a low result as previously described by Wians et al? All urine samples to be assayed must be tested for their protein concentration with a dipstick prior to assay, and if the colour change is blue-green (i.e. > 4 +) the urine should be diluted 50-fold with deionized water and assayed.
Crofton used a Centrifree micropartition system (Amicon Ltd, Stonehouse, Glos, UK) to produce 'protein-free ultrafiltrates' for analysis by the two protein methods. The difference observed in the protein concentrations between the two methods on the 'ultrafiltrate' was used as evidence for a non-protein interference in the benzethonium chloride method. However, there was some protein detected in the 'ultrafiltrate' as measured by the SSA method. Since the molecular size cut-off for the filters was not stated, the size range of proteins present in the 'ultrafiltrate' is not known.
A number of urine proteins have been found to be soluble in SSA therefore rendering them undetectable in methods using this acid. In one study 13 urine proteins with molecular weights ranging from 15000-230000 Da were shown to be soluble in SSA and not precipitated by this acid. ' The major protein found in these urine samples was the acute phase reactant oc-I-acid glycoprotein.
It is possible that low molecular weight glycoproteins that are soluble in SSA may be present in the urine samples of patients with acute phase reactions and may not be detected by this method. An inhibitor that decreases the analytical recovery of proteins in the SSA method could also be present. The results reported by Crofton from the benzethonium chloride 88 Ann Clin Biochem 1990; 27: 88-96 method may have indeed been a true reflection of the patient's urine protein concentration. It is not possible to rule out this sort of error unless another protein assay that does not use SSA was used to determine the total protein, such as the Coomassie brilliant blue method. Another approach is to electrophorese the urine samples to determine the range of proteins present in the specimen.
In conclusion, it is premature to say that the benzethonium chloride method is giving falsely high protein values until the author can be certain that the SSA method used as a reference method is not suffering from a negative interference within these urines. The membrane in the Centrifree micropartition system (Amicon Ltd), used to prepare the protein-free ultrafiltrates of urine as described in my report,' had a molecular size cut-off of 30000Da. According to the manufacturers this gives a 90-95% solute rejection at molecular sizes of 25 500-67000 Da. Alpha-I-acid glycoprotein, quantitatively by far the most important of the low molecular size SSA-soluble proteins in patients' urine/ has a molecular size of 45000 Da and would therefore be largely retained by this membrane. One of the urine samples which exhibited a marked discrepancy between the benzethonium chloride method (apparent protein concentration 2320 mg/L) and the SSA method (apparent protein concentration 595 mg/L) was subjected to concentration (molecular size cut-off 15000Da) followed by protein electrophoresis. Albumin comprised 13·8% and (X-I-globulin 18·4% of the protein present (the remainder being largely 'l'-globulin). Even assuming that all the (X-I-globulin fraction was (X-I-acid glycoprotein and that a maximum of 10% of this protein appeared in the Centrifree ultrafiltrate, the expected concentration in the ultrafiltrate would be II rng/L (SSA method) or 43 mg/L (benzethonium chloride method). The corresponding measured concentrations were IS rng/L and 550 mg/L, respectively. The small fraction of (X-I-acid glycoprotein which may have appeared in the ultrafiltrate of this particular sample was insufficient to account for the apparent protein concentration measured by the benzethonium chloride method.
The possible presence of an inhibitor that might decrease the analytical recovery of proteins in the SSA method is made less likely by the experiment described in my original report in which three ultrafiltrates were mixed with a urine sample containing 380 rng/L protein by both methods. No negative interference was found.
Although I accept that some urine samples may contain proteins soluble in SSA, resulting in variable underestimation of protein by this method, the evidence suggests that the benzethonium chloride method overestimates urinary protein for certain urine samples and their ultrafiltrates . 
